期刊文献+

5-羟色胺转运蛋白基因多态性与抗抑郁药临床疗效的关系 被引量:9

Relationship of clinical response between 5-HTT gene polymorphism and plasma 5- HT lever
下载PDF
导出
摘要 目的:研究南京地区人群中5-羟色胺转运蛋白(5-HTT)基因多态性与血浆5-羟色胺(5-HT)浓度及选择性5-羟色胺再摄取抑制剂(SSRIs)的抗抑郁临床疗效是否存在相关性。方法;采用聚合酶链式反应(PCR)多态性分析技术对132例抑郁症患者和100名健康者进行基因型分析;HPLC-ECD法分析血浆中5-HT浓度;用汉密尔顿抑郁量表(HAMD)评定抗抑郁药的疗效。结果:抑郁症5-HTT基因基因型频率(LL24.2%,LS44.7%,SS31.1%)、等位基因频率(L46.59%,S53.41%);与正常对照组基因型频率(LL29.0%,LS47.0%,SS24.0%)、等位基因频率(L52.5%,S47.5%)比较无显著性差异(P>0.05);不同基因型抑郁症患者治疗前HAMD总分有显著差异,F=6.48,P=0.0021:经4wk SSRIs类抗抑郁药治疗后,HAMD总分均显著下降,减分值有显著差异,F=3.38,P=0.037;治疗前不同基因型患者5-HT浓度有显著差异,F=5.38,P=0.005 7;4wk治疗后,血浆中5-HT浓度均升高,不同基因型的增高值有明显差异,F=23.55,P<0.01。结论:南京地区人群中5-HTT基因多态性与抑郁症的发病不存在相关性,但与抑郁症疾病严重程度和SSRIs治疗效应存在显著的相关性,这一区域的基因型可能成为抑郁症患者实现个体化治疗的一个参考指标。 AIM: To investigate the relationship between 5-hydroxytryptamine transporter (5-HTT) gene polymorphism and plasma 5-hydroxytryptamine (5-HT) lever, clinical response of selective serotonin reuptacke inhibitors (SS-RIs) in Chinese depressive patients. METHODS: Polymerase chain reaction (PCR) was used to detect the polymorphism of 5-HTT gene in 132 depressive patients and 100 controls. HPLC-electrical chemistry detector method was used to analyse plasma 5-HT lever. The depressive states were assessed with Hamilton Depression Rating Scale (HAMD). RESULTS: There were no significant differences of the 5-HTT polymorphism genotypes and alleles between 132 depressive patients (LL24.2%, LS44.7%, 3531.1%; L46.59%, 853.41%) and 100 controls (LL29.0%, 1547.0%, SS 24.0% ; L 52.5 % , S 47.5%), P > 0.05. The HAMD and plasma 5-HT lever of pre-treatment were significant differences in depressive patients with different 5-HTT genotype (F = 6.48, P = 0.002 1; F = 5.38, P =0.005 7). The HAMD reductive date and plasma 5-HT lever increasing date of 4 wk SSRIs post treatment were significant differences in depressive patients with different 5-HTT genotype ( F = 3.38, P < 0.01; F = 23.55, P < 0.01). CONCLUSION: The 5-HTT polymorphism is not associated with depression, but is associated with disease serious degree and SSRIs clini- cal responses in Chinese.
出处 《中国临床药学杂志》 CAS 2003年第4期204-207,共4页 Chinese Journal of Clinical Pharmacy
基金 1999年度江苏省教育厅自然科学基金 编号:1999032
关键词 5-羟色胺 转运蛋白 基因多态性 抗抑郁药 临床疗效 5-hydroxytryptamine transporter genetic polymorphism selective serotonin reuptacke inhibitors
  • 相关文献

参考文献4

  • 1Heils A, Tenfel A. Petri S, et al. Allelic variation of human serotonin transporter gene expression[J]. J Neurochem, 1996,66(6):2621. 被引量:1
  • 2Smeraldi E, Zanardi R, Benedetti F, et al. Polymolphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine[J]. Mol Psychiatry, 1998,3(6) :508. 被引量:1
  • 3Zanardi R, Benedetti F, Di Bella D, et al. Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of serotonin transporter gene[J]. J Clin Psychopharmacol,2000,20(1) :105. 被引量:1
  • 4Lesch KP, Bengel D, Heils A, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulayory region[J]. Science, 1996,274(5292) : 1527. 被引量:1

同被引文献205

引证文献9

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部